Zevra Therapeutics, Inc. (ZVRA)

8.80 -0.09 (-1.01%) USD  |  NASDAQ  |  Feb 20, 16:00
8.88 +0.08 (+0.91%) After-Hours: 07:22
More

Zevra Therapeutics Capital Expenditures (Quarterly)

Capital Expenditures (Quarterly) Chart

View Capital Expenditures (Quarterly) for ZVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Capex Definition

View Capex Definition
Start Trial

Capital expenditures are a line item from a company's statement of cash flows.

Read full definition.

Capital Expenditures (Quarterly) Range, Past 5 Years

View Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Capital Expenditures (Quarterly) Benchmarks

View Capital Expenditures (Quarterly) Benchmarks
Start Trial
Verastem, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade